You are here

  • Home
  • Archive
  • Volume 22, Issue 1
  • Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma: A Feasibility Study

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma: A Feasibility Study

Authors

  1. Address correspondence and reprint requests to Shoji Nagao, MD, PhD, Department of Gynecologic Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-City 350-1241, Japan. E-mail: s_nagao{at}saitama-med.ac.jp.

Citation

Nagao S, Iwasa N, Kurosaki A, et al
Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma: A Feasibility Study
International Journal of Gynecologic Cancer 2012;22:70-75.

Publication history

  • Received June 21, 2011
  • Accepted August 29, 2011
  • First published January 1, 2012.
Online issue publication 
June 17, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2012 by IGCS and ESGO